Using IMRT to Treat Adenoid Cystic Carcinomas in the Head and Neck
Author Information
Author(s): Münter MW, Schulz-Ertner D, Hof H, Nikoghosyan A, Jensen A, Nill S, Huber P, Debus J
Primary Institution: German Cancer Research Center (dkfz), Heidelberg, Germany
Hypothesis
Is inverse planned stereotactic intensity modulated radiotherapy (IMRT) effective in treating adenoid cystic carcinomas of the head and neck?
Conclusion
The inverse planned stereotactic IMRT is feasible in the treatment of ACC, achieving high control rates and low side effects.
Supporting Evidence
- The three-year overall survival rate was 72%.
- The three-year recurrence-free survival was 38%.
- Acute side effects >Grade II appeared in a small number of patients.
Takeaway
Doctors used a special type of radiation therapy to treat patients with a specific kind of cancer in the head and neck, and it worked well with few side effects.
Methodology
25 patients with adenoid cystic carcinomas were treated using inverse planned IMRT, with follow-up evaluations conducted over a median of 22.5 months.
Limitations
The study had a small sample size and a relatively short follow-up period.
Participant Demographics
Patients aged 30 to 80 years, with 12 females and 13 males.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website